Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 3/20 | 0.50 |
| ▸ | BCR | P11274 | 3/20 | 0.50 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.49 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.49 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | SLC6A7 | Q99884 | 2/20 | 0.45 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.45 |
| ▸ | HTR2B | P41595 | 2/20 | 0.45 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.45 |
| ▸ | HTR1A | P08908 | 1/20 | 0.45 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.45 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.45 |
| ▸ | HRH2 | P25021 | 1/20 | 0.45 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.45 |
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
| ▸ | HTR2C | P28335 | 1/20 | 0.45 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5451315 | 0.98 | ABL1 (0.50) | ABL1BCRMKNK1MKNK2HRH3 | |
| SCHEMBL5468207 | 0.90 | POLB (0.56) | HRH3KDM4ESLC6A7TMEM97SIGMAR1 | |
| SCHEMBL5464881 | 0.86 | KDM4E (0.60) | HRH3KDM4ETMEM97SIGMAR1HTR2B | |
| SCHEMBL5465885 | 0.83 | KDM4E (0.60) | HRH3KDM4ETMEM97SIGMAR1HTR2B | |
| SCHEMBL5459697 | 0.83 | L3MBTL3 (0.57) | HRH3KDM4ETMEM97SIGMAR1HTR2B | |
| SCHEMBL14440465 | 0.81 | HRH3 (0.53) | HRH3KDM4ETMEM97SIGMAR1HTR2B | |
| SCHEMBL5459085 | 0.81 | L3MBTL3 (0.52) | HRH3KDM4ETMEM97SIGMAR1HTR2B | |
| SCHEMBL5472454 | 0.81 | HRH3 (0.64) | HRH3KDM4ETMEM97SIGMAR1HTR2B | |
| SCHEMBL14440657 | 0.80 | HRH3 (0.56) | HRH3TMEM97SIGMAR1HTR2BCHRM4 | |
| SCHEMBL1169580 | 0.79 | MKNK1 (0.60) | ABL1BCRMKNK1MKNK2HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070185089-A1 | Benzazepine derivatives for the treatment of neurological and psychiatric disorders | GLAXO GROUP LIMITED (GB) | 2007-08-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070185089-A1 | Benzazepine derivatives for the treatment of neurological and psychiatric disorders | CNR2, GRIN2C, GRIN2B | ABL1 1452/4885BCR 2568/4885MKNK1 3632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.